Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Kursexplosion von 383 % seit November und massiver Solana-Outperformer!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
81 Leser
Artikel bewerten:
(0)

Ultrasound Market worth $13.87 billion in 2030 with 6.8% CAGR | MarketsandMarkets

Finanznachrichten News

DELRAY BEACH, Fla., Jan. 22, 2025 /PRNewswire/ -- The global Ultrasound Market, The global ultrasound market, valued at US$8.65 billion in 2023, is forecasted to grow at a robust CAGR of 6.8%, reaching US$9.32 billion in 2024 and an impressive US$13.87 billion by 2030. The ultrasound market is experiencing significant growth due to several key factors. One major driver is the rising prevalence of chronic diseases, such as cardiovascular conditions, cancer, and musculoskeletal disorders, which require advanced diagnostic tools. Additionally, there is increasing demand for non-invasive, real-time imaging techniques and a growing emphasis on the early detection of medical conditions, both of which further propel the market. Technological advancements, including the integration of artificial intelligence, 3D and 4D imaging, and the development of portable ultrasound devices, have enhanced the versatility and accessibility of ultrasound technology. As a result, it is becoming more widely utilized in healthcare institutions.

MarketsandMarkets_Logo

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=467

Browse in-depth TOC on "Ultrasound Market"

478 - Tables
57 - Figures
419 - Pages

By display, Color ultrasound segment to command the highest growth rate during the study period. Color ultrasound shows the maximum growth rate in the market for ultrasound as it can easily produce high-resolution, real-time images to improve diagnostic efficacy for diverse applications. As the equipment can be fitted with Doppler technology, thus creating possible images of blood dynamics and other tissue movements and conditions within blood vessels, these ultrasound apparatuses are one of the most important in diagnosis cases related to cardiovascular disorder diagnosis and monitoring pregnancy in obstetrics and examining vascular disease. Increased rates of chronic diseases, particularly heart disease and diabetes that may have complications of the vessels, create the demand for color ultrasound machines.

By Application Vascular applications account for highest CAGR in the Ultrasound Market in 2023. Vascular applications account for highest CAGR in 2023. With vascular diseases such as atherosclerosis, deep vein thrombosis, and peripheral artery disease increasingly diagnosed, applications for the use of ultrasound have recorded the highest growth rate in this market. Ultrasound presents a non-invasive method to evaluate blood flow in patients, detect blockages and view conditions within vessels in real time; it is an essential diagnostic tool in vascular diagnostics, being cost-effective and very precise. Technological development, such as 3D/4D imaging and Doppler ultrasound, has increased the accuracy and ability of vascular imaging that makes it increasingly popular among clinicians. Furthermore, increased awareness about vascular health due to an aging population combined with the necessity of making an early diagnosis has played a crucial role in enhancing the growth of ultrasound-based vascular applications.

By geography, Europe holds the largest market share in the ultrasound business for several key reasons. Strong regulation in Europe ensures that the standards for medical devices are very high and, thus, encourages trust in ultrasound technology. The second factor is that the region focuses much on innovation and research in medical imaging with significant investments in healthcare R&D. It encourages advanced ultrasound technologies. Thirdly, the massive availability of trained healthcare professionals in Europe who can use ultrasound for diagnostics will ensure effective adoption and usage. In addition to this, the demand for portable, point-of-care ultrasound devices for emergency and rural areas also is being fostered in Europe, which is thereby extending the demand for the product. Finally, the growing awareness of the benefits of ultrasound use, such as non-invasive in nature and cost-effective among health care professionals and patients, accelerates its spread throughout the region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=467

As of 2023, prominent players in the Ultrasound market are Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan), among others.

GE Healthcare (US):

GE Healthcare is a leader in medical technology, diagnostics, and digital solutions with a wide range in their ultrasound segment portfolio. Their portfolio ranges of ultrasounds include advanced systems specifically tailored for applications like cardiology, radiology, obstetrics and gynecology, musculoskeletal imaging, and point-of-care diagnostics, and so on.. Its state-of-the-art features also include AI-assisted imaging and high-definition resolution as well as portable designs for improvement in diagnostic accuracy and access. Within these areas, such as in women's health with the Voluson series, general imaging with the LOGIQ series, versatile handhelds like the Vscan Air complete the comprehensive offering from the company to satisfy all clinician needs in any healthcare setting.

Philips Healthcare (Netherlands):

Philips Healthcare, represents the most comprehensive provider in health technology solutions. From improving patient care to health results, Philips delivers innovation throughout its product offerings. Its array of products ranges from medical imaging systems to patient care, connected care, as well as precision diagnosis systems. Under ultrasound, its solutions have specialties related to cardiology, obstetrics and gynecology, general imaging, and point-of-care applications. Among those, the EPIQ and Affiniti series include AI-driven enhancements with good image quality, ergonomic design, and empower clinicians to carry out accurate and efficient diagnostics. Portable solutions, such as the Lumify, can provide the versatility and accessibility of ultrasound capabilities in diverse healthcare settings from hospitals to remote ones.

Mindray Medical International Limited (China):

Mindray is a global company in the medical device and solutions, founded in 1991, with four product categories: In-Vitro Diagnostics, Patient Monitoring and Life Support, Veterinary and Medical Imaging System.Mindray serves healthcare institutions around the world with a comprehensive range of high-quality, cost-effective products, emphasizing research and development on staying at the forefront in medical technology. With R&D centers and subsidiaries in a number of countries, Mindray is dedicated to raising healthcare accessibility and remains one of the trusted partners within the medical community.

For more information, Inquire Now!

Related Reports:

Medical Equipment Maintenance Market

Diagnostic Imaging Services Market

Veterinary Ultrasound Market

Electrosurgery Market

Minimally Invasive Surgical Instruments Market

Get access to the latest updates on Ultrasound Companies and Ultrasound Market Size

About MarketsandMarkets:

MarketsandMarkets has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/ultrasound-market-worth-13-87-billion-in-2030-with-6-8-cagr--marketsandmarkets-302356990.html

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.